Houttuynia cordata Thunb extract modulates G0/G1 arrest and Fas/CD95-mediated death receptor apoptotic cell death in human lung cancer A549 cells

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Chen, Yuh Fung ^a   Yang, Jai Sing ^a   Chang, Wen Shin ^a   Tsai, Shih Chang ^b   Peng, Shu Fen ^b   Zhou, Yuan Ru ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Fas CD95; G0 G1 arrest; Houttuynia cordata Thunb (HCT); Lung cancer A549 cells

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CASPASE 8; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; DEATH RECEPTOR; DNA; FAS ANTIGEN; HOUTTUYNIA CORDATA THUNB EXTRACT; PLANT EXTRACT; PROTEIN P27; UNCLASSIFIED DRUG; HERBACEOUS AGENT; PLANT EXTRACT, HOUTTUYNIA CORDATA;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL POPULATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; COMET ASSAY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LUNG CANCER; POLYMERIZATION; PRIORITY JOURNAL; WESTERN BLOTTING; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

HOUTTUYNIA CORDATA;

ANTIGENS, CD95; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUGS, CHINESE HERBAL; G0 PHASE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION;

EID: 84875082669     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-18     Document Type: Article

References (53)

1. Therapeutic advances in non-small cell lung cancer. Vallieres E, Peters S, Van Houtte P, Dalal P, Lim E, Thorax 2011 67 12 1097 1101 22058187
2. Current management of small cell lung cancer. Neal JW, Gubens MA, Wakelee HA, Clin Chest Med 2011 32 4 853 863 10.1016/j.ccm.2011.07.002 22054891
3. Status of particle therapy for lung cancer. Liao Z, Lin SH, Cox JD, Acta Oncol 2011 50 6 745 756 10.3109/0284186X.2011.590148 21767170
4. Molecular targeted therapies in small-cell lung cancer. Levy A, Malouf GG, Besse B, Massard C, Soria JC, Bull Cancer 2010 97 5 535 545 20093224
5. Targeting cancer with phosphodiesterase inhibitors. Savai R, Pullamsetti SS, Banat GA, Weissmann N, Ghofrani HA, Grimminger F, Schermuly RT, Expert Opin Investig Drugs 2010 19 1 117 131 10.1517/13543780903485642 20001559
6. Non-receptor tyrosine kinase inhibitors in lung cancer. Hahn O, Salgia R, Anticancer Agents Med Chem 2007 7 6 633 642 10.2174/187152007784111322 18045058 (Pubitemid 350237768)
7. Molecular abnormalities in lung cancer. Salgia R, Skarin AT, J Clin Oncol 1998 16 3 1207 1217 9508209 (Pubitemid 28108759)
8. Live or let die: manipulation of cellular suicide programs by murine cytomegalovirus. Handke W, Krause E, Brune W, Med Microbiol Immunol 2012 201 4 475 486 10.1007/s00430-012-0264-z 22965170
9. Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. Sanmartin C, Plano D, Sharma AK, Palop JA, Int J Mol Sci 2012 13 8 9649 9672 22949823
10. Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer. Wen X, Lin ZQ, Liu B, Wei YQ, Cell Prolif 2012 45 3 217 224 10.1111/j.1365-2184.2012.00814.x 22429822
11. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Kantari C, Walczak H, Biochim Biophys Acta 2011 1813 4 558 563 10.1016/j.bbamcr.2011.01.026 21295084
12. CD95-Mediated cell signaling in cancer: mutations and post-translational modulations. Tauzin S, Debure L, Moreau JF, Legembre P, Cell Mol Life Sci 2012 69 8 1261 1277 10.1007/s00018-011-0866-4 22042271
13. Does calcium contribute to the CD95 signaling pathway? Vacher P, Khadra N, Vacher AM, Charles E, Bresson-Bepoldin L, Legembre P, Anticancer Drugs 2011 22 6 481 487 10.1097/CAD.0b013e32834433ea 21317766
14. Fas death receptor signalling: roles of Bid and XIAP. Kaufmann T, Strasser A, Jost PJ, Cell Death Differ 2012 19 1 42 50 10.1038/cdd.2011.121 21959933
15. The Fas/CD95 receptor regulates the death of autoreactive B cells and the selection of antigen-specific B cells. Koncz G, Hueber AO, Front Immunol 2012 3 207 22848207
16. Fas-associated death domain protein and adenosine partnership: fad in RA. Vilmont V, Tourneur L, Chiocchia G, Rheumatology (Oxford) 2012 51 6 964 975 10.1093/rheumatology/ker402
17. Programmed cell death in Parkinson's disease. Venderova K, Park DS, Cold Spring Harb Perspect Med 2012 2 009365 22908196
18. Role of PARP and protein poly-ADP-ribosylation process in regulation of cell functions. Drel VR, Shymans'kyi IO, Sybirna NO, Velykyi MM, Ukr Biokhim Zh 2011 83 6 5 34 22364016
19. Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes. Agarwal A, Mahfouz RZ, Sharma RK, Sarkar O, Mangrola D, Mathur PP, Reprod Biol Endocrinol 2009 7 143 10.1186/1477-7827-7-143 19961617
20. The PARP superfamily. Ame JC, Spenlehauer C, de Murcia G, Bioessays 2004 26 8 882 893 10.1002/bies.20085 15273990 (Pubitemid 39128102)
21. Poly(ADP-ribose) makes a date with death. Heeres JT, Hergenrother PJ, Curr Opin Chem Biol 2007 11 6 644 653 10.1016/j.cbpa.2007.08.038 17936669 (Pubitemid 350180567)
22. Antileukemic activity of Bidens pilosa L. var. minor (Blume) Sherff and Houttuynia cordata Thunb. Chang JS, Chiang LC, Chen CC, Liu LT, Wang KC, Lin CC, Am J Chin Med 2001 29 2 303 312 10.1142/S0192415X01000320 11527072
23. Treatment of bovine mastitis with houttuynin sodium bisulphate. Hu SH, Du AF, Zentralbl Veterinarmed B 1997 44 6 365 370 9283287 (Pubitemid 127524135)
24. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV. Hayashi K, Kamiya M, Hayashi T, Planta Med 1995 61 3 237 241 10.1055/s-2006-958063 7617766
25. Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. Park E, Kum S, Wang C, Park SY, Kim BS, Schuller-Levis G, Am J Chin Med 2005 33 3 415 424 10.1142/S0192415X05003028 16047559 (Pubitemid 40909139)
26. Antioxidative activity, polyphenolic content and anti-glycation effect of some thai medicinal plants traditionally used in diabetic patients. Kusirisin W, Srichairatanakool S, Lerttrakarnnon P, Lailerd N, Suttajit M, Jaikang C, Chaiyasut C, Med Chem 2009 5 2 139 147 10.2174/157340609787582918 19275712
27. The effect of Houttuynia cordata injection on pseudorabies herpesvirus (PrV) infection in vitro. Ren X, Sui X, Yin J, Pharm Biol 2011 49 2 161 166 10.3109/13880209.2010.505242 20942608
28. Houttuynia cordata blocks HSV infection through inhibition of NF-kappaB activation. Chen X, Wang Z, Yang Z, Wang J, Xu Y, Tan RX, Li E, Antiviral Res 2011 92 2 341 345 10.1016/j.antiviral.2011.09.005 21951655
29. Immunomodulatory and anti-SARS activities of Houttuynia cordata. Lau KM, Lee KM, Koon CM, Cheung CS, Lau CP, Ho HM, Lee MY, Au SW, Cheng CH, Lau CB, Tsui SK, Wan DC, Waye MM, Wong KB, Wong CK, Lam CW, Leung PC, Fung KP, J Ethnopharmacol 2008 118 1 79 85 10.1016/j.jep.2008.03.018 18479853
30. Ethanolic extract of fermented Houttuynia cordata Thunb induces human leukemic HL-60 and Molt-4 cell apoptosis via oxidative stress and a mitochondrial pathway. Banjerdpongchai R, Kongtawelert P, Asian Pac J Cancer Prev 2011 12 11 2871 2874 22393956
31. Houttuynia cordata Thunb fraction induces human leukemic Molt-4 cell apoptosis through the endoplasmic reticulum stress pathway. Prommaban A, Kodchakorn K, Kongtawelert P, Banjerdpongchai R, Asian Pac J Cancer Prev 2012 13 5 1977 1981 10.7314/APJCP.2012.13.5.1977 22901157
32. Houttuynia cordata Thunb extract induces apoptosis through mitochondrial-dependent pathway in HT-29 human colon adenocarcinoma cells. Tang YJ, Yang JS, Lin CF, Shyu WC, Tsuzuki M, Lu CC, Chen YF, Lai KC, Oncol Rep 2009 22 5 1051 1056 19787220
33. Houttuynia cordata Thunb extract inhibits cell growth and induces apoptosis in human primary colorectal cancer cells. Lai KC, Chiu YJ, Tang YJ, Lin KL, Chiang JH, Jiang YL, Jen HF, Kuo YH, Agamaya S, Chung JG, Yang JS, Anticancer Res 2010 30 9 3549 3556 20944136
34. Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells. Zhou NN, Tang J, Chen WD, Feng GK, Xie BF, Liu ZC, Yang D, Zhu XF, Life Sci 2012 90 19-20 770 775 22525372
35. Novel anti-leukemia activities of pipoxolan operate via the mitochondria-related pathway in human leukemia U937 cells and attenuate U937 cell growth in an animal model. Chen YF, Yang JS, Huang WW, Tsai HY, Molecular Medicine Reports 2010 3 5 851 856 21472325
36. Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-2 OS cells. Huang WW, Chiu YJ, Fan MJ, Lu HF, Yeh HF, Li KH, Chen PY, Chung JG, Yang JS, Mol Nutr Food Res 2010 54 11 1585 1595 10.1002/mnfr.201000005 20564475
37. Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Huang WW, Ko SW, Tsai HY, Chugn JG, Chiang JH, Chen KT, Chen YC, Chen YF, Yang JS, Int J Oncol 2011 38 4 1067 1073 21271215
38. Death receptor 5-mediated TNFR family signaling pathways modulate gamma-humulene-induced apoptosis in human colorectal cancer HT29 cells. Lan YH, Wu YC, Wu KW, Chung JG, Lu CC, Chen YL, Wu TS, Yang JS, Oncol Rep 2011 25 2 419 424 21152878
39. Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer. Guo L, Fan L, Ren J, Pang Z, Ren Y, Li J, Wen Z, Qian Y, Zhang L, Ma H, Jiang X, Int J Nanomedicine 2012 7 1449 1460 22619505
40. Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Jin H, Yang R, Ross J, Fong S, Carano R, Totpal K, Lawrence D, Zheng Z, Koeppen H, Stern H, Schwall R, Ashkenazi A, Clin Cancer Res 2008 14 23 7733 7740 10.1158/1078-0432.CCR-08- 0670 19047100
41. Traditional chinese medicine in cancer care: a review of case series published in the chinese literature. Yang G, Li X, Wang L, Li J, Song X, Chen J, Guo Y, Sun X, Wang S, Zhang Z, Zhou X, Liu J, Evid Based Complement Alternat Med 2012 2012 751046 22778776
42. Chinese medicine pattern differentiation and its implications for clinical practice. Ferreira AS, Lopes AJ, Chin J Integr Med 2011 17 11 818 823 10.1007/s11655-011-0892-y 22057410
43. Use of compound Chinese medicine in the treatment of lung cancer. Tian G, Guo L, Gao W, Curr Drug Discov Technol 2010 7 1 32 36 10.2174/ 157016310791162776 20156141
44. The illustrated medicinal plants of taiwan, Chiu NY CK, 1986
45. Determination of flavonoids in Houttuynia cordata Thunb. and Saururus chinensis (Lour.) Bail. by capillary electrophoresis with electrochemical detection. Xu X, Ye H, Wang W, Yu L, Chen G, Talanta 2006 68 3 759 764 10.1016/j.talanta.2005.05.027 18970387 (Pubitemid 43052484)
46. The constituents and their bioactivities of Houttuynia cordata Thunb. Chou SC, Ku YC, Wu TS, Chem Pharm Bull 2009 57 11 1227 1230 10.1248/cpb.57.1227 19881272
47. Studies on chemical constituents of phenols in fresh Houttuynia Cordata. Meng J, Dong XP, Zhou YS, Jiang ZH, Leung SY, Zhao ZZ, Zhongguo Zhong Yao Za Zhi 2007 32 10 929 931 17655149
48. The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy. Grant S, Roberts JD, Drug Resist Updat 2003 6 1 15 26 10.1016/S1368-7646(02)00141-3 12654284 (Pubitemid 36396111)
49. Cyclin-dependent kinases: engines, clocks, and microprocessors. Morgan DO, Annu Rev Cell Dev Biol 1997 13 261 291 10.1146/annurev.cellbio.13.1.261 9442875 (Pubitemid 28034527)
50. Cyclin-dependent kinase inhibitors. Dai Y, Grant S, Curr Opin Pharmacol 2003 3 4 362 370 10.1016/S1471-4892(03)00079-1 12901944 (Pubitemid 36908939)
51. Cell cycle and apoptosis: common pathways to life and death. King KL, Cidlowski JA, J Cell Biochem 1995 58 2 175 180 10.1002/jcb.240580206 7673325
52. Impact of the cyclin-dependent kinase inhibitors p27kip1 on resistance of tumor cells to anticancer agents. St Croix B, Florenes VA, Rak JW, Bhattacharya N, Slingerland JM, Kerbel RS, Nat Med 1996 2 1204 1210 10.1038/nm1196-1204 8898746 (Pubitemid 26375403)
53. Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells. Niu MY, Menard M, Reed JC, Krajewski S, Pratt MA, Oncogene 2001 20 3506 3518 10.1038/sj.onc.1204453 11429697 (Pubitemid 32619403)